Chen R X, Shi J Y, Ren Y Q, Wang F, Zhou Y P, Cui Y
Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200062, China.
Zhonghua Yi Xue Za Zhi. 2019 Dec 17;99(47):3715-3719. doi: 10.3760/cma.j.issn.0376-2491.2019.47.008.
To observe the clinical features and effects of extracorporeal membrane oxygenation (ECMO) in critically ill children with acute fulminant myocarditis (AFM). A retrospective analysis was performed in pediatric patients with AFM requiring ECMO, from December 2015 to December 2018, who were admitted to the Pediatric Intensive Care Unit (PICU) in Shanghai Children's Hospital. According to whether patient was alive at least 48 hours after weaning, the children were divided into successful weaning group (9 cases) and unsucessful weaning group (3 cases). The factors related to successful ECMO weaning were explored. The changes of clinical and biochemical parameters before and after ECMO treatment in successful weaning group were analyzed. Continuous variables were presented as median (inter quartile range) for abnormal distribution data, and Mann-Whitney test was used to compare the data. A total of 12 pediatric patients including 4 males and 8 females were enrolled in this study. The median body weight was 20 (17, 36) kg, and the median age was 66 (48, 103) months. Nine cases were successfully weaned from ECMO, and 8 cases survived to discharge, and 4 cases died in the hospital. The median interval between symptoms onset and ECMO establishment was 3.0 (2.2, 4.0) days, the median duration of ECMO support was 120 (68, 152) hours. In the unsuccessful weaning group, patients displayed higher levels of initiallactic acid (LA), higher vasoactive-inotropic score (VIS), and longer QRS duration before ECMO establishment when compared with those in the successful weaning group (all 0.05). After ECMO establishment, mean arterial pressure (MAP), systemic central venous oxygen saturation, LA, myocardial injury markers and left ventricular ejection fraction were all significantly improved in the successful weaning group (all 0.05). In pediatric AFM patients, serum LA level, VIS and QRS duration before ECMO establishment are associated with successful ECMO weaning.
观察体外膜肺氧合(ECMO)在儿童急性暴发性心肌炎(AFM)危重症患者中的临床特征及效果。对2015年12月至2018年12月在上海儿童医学中心儿科重症监护病房(PICU)接受ECMO治疗的AFM患儿进行回顾性分析。根据患儿脱机后至少存活48小时与否,将患儿分为成功脱机组(9例)和未成功脱机组(3例)。探讨与ECMO成功脱机相关的因素。分析成功脱机组ECMO治疗前后临床及生化参数的变化。对于呈非正态分布的数据,连续变量以中位数(四分位数间距)表示,并采用Mann-Whitney检验比较数据。本研究共纳入12例儿科患者,其中男性4例,女性八例。中位数体重为20(17,36)kg,中位数年龄为66(48,103)个月。9例成功脱机,8例存活出院,4例院内死亡。症状出现至建立ECMO的中位间隔时间为3.0(2.2,4.0)天,ECMO支持的中位持续时间为120(68,152)小时。与成功脱机组相比,未成功脱机组患者在建立ECMO前初始乳酸(LA)水平更高、血管活性药物-正性肌力药物评分(VIS)更高、QRS时限更长(均P<0.05)。建立ECMO后,成功脱机组的平均动脉压(MAP)、全身中心静脉血氧饱和度、LA、心肌损伤标志物及左心室射血分数均显著改善(均P<0.05)。在儿童AFM患者中,建立ECMO前的血清LA水平、VIS及QRS时限与ECMO成功脱机相关。